Data Safety Monitoring Board recommends continuation of phase 1/2 clinical trial with Sernova’s Cell Pouch System™ in patients with Type-1 Diabetes

Sernova Corp., a clinical- stage company and leader in regenerative medicine cell therapeutics, is pleased to announce that the Data Safety Monitoring Board (“DSMB”) has completed the third annual review of Sernova’s ongoing Phase 1/2 clinical study “Safety, Tolerability and Efficacy Study of Sernova’s Cell Pouch for Clinical Islet Transplantation” in patients with Type-1 Diabetes…

Info-Tech Research Group Grows to 1,000 Employees

Info-Tech Research Group, a global IT research and advisory firm based out of London, Ontario, has recently announced a significant milestone for the organization.  As Info-Tech enters its twenty-fifth year of business, the firm has surpassed anticipated growth metrics and is now employing over 1,000 employees. In 2021, Info-Tech expanded its employee base by 43%…